BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16034872)

  • 1. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002088. PubMed ID: 16034872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2002; (4):CD002088. PubMed ID: 12519567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2001; (2):CD002088. PubMed ID: 11406032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech and language therapy for dysarthria due to nonprogressive brain damage: a systematic Cochrane review.
    Sellars C; Hughes T; Langhorne P
    Clin Rehabil; 2002 Feb; 16(1):61-8. PubMed ID: 11837527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury.
    Mitchell C; Bowen A; Tyson S; Butterfint Z; Conroy P
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002088. PubMed ID: 28121021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech and language therapy for aphasia following stroke.
    Brady MC; Kelly H; Godwin J; Enderby P; Campbell P
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD000425. PubMed ID: 27245310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Parker NK; Kelly H; Miller N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for apraxia of speech following stroke.
    West C; Hesketh A; Vail A; Bowen A
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD004298. PubMed ID: 16235357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech and language therapy for aphasia following stroke.
    Greener J; Enderby P; Whurr R
    Cochrane Database Syst Rev; 2000; (2):CD000425. PubMed ID: 10796360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention for dysarthria associated with acquired brain injury in children and adolescents.
    Morgan AT; Vogel AP
    Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006279. PubMed ID: 18646143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech and language therapy for aphasia following stroke.
    Brady MC; Kelly H; Godwin J; Enderby P
    Cochrane Database Syst Rev; 2012 May; (5):CD000425. PubMed ID: 22592672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech and language therapy for aphasia following stroke.
    Kelly H; Brady MC; Enderby P
    Cochrane Database Syst Rev; 2010 May; (5):CD000425. PubMed ID: 20464716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech and language therapy interventions for children with primary speech and language delay or disorder.
    Law J; Garrett Z; Nye C
    Cochrane Database Syst Rev; 2003; 2003(3):CD004110. PubMed ID: 12918003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Miller N; Robson S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006937. PubMed ID: 19821391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of non-progressive dysarthria: practice patterns of speech and language therapists in the Republic of Ireland.
    Conway A; Walshe M
    Int J Lang Commun Disord; 2015; 50(3):374-88. PubMed ID: 25652223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for promoting participation in shared decision-making for children with cancer.
    Coyne I; O'MathĂșna DP; Gibson F; Shields L; Sheaf G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008970. PubMed ID: 23740765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.